Commercialise
Avecho and Sandoz enter Unique License and Improvement Settlement to Commercialise CBD for Insomnia in Australia
Avecho Biotechnology Restricted (ASX: AVE) (“Avecho” or the “Firm”) at the moment introduced it has signed an unique ten-year growth and licensing settlement with Sandoz Group AG (“Sandoz”) for the business rights to Avecho’s Section III cannabidiol (“CBD”) capsule for insomnia in Australia. Avecho retains the rights to commercialise the product in all different territories, […]